An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis.
Oncoimmunology
; 11(1): 2115618, 2022.
Article
in En
| MEDLINE
| ID: mdl-36046810
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cancer Vaccines
/
Melanoma
Limits:
Animals
Language:
En
Journal:
Oncoimmunology
Year:
2022
Document type:
Article
Affiliation country:
Suecia
Country of publication:
Estados Unidos